A Song of Life

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-10-01-2001
Volume 0
Issue 0

I heard the first bird of the morning whistling to his lover. Their small wings owned the sky again while the people fled for cover.

Articles in this issue
National Crisis Supercedes Coverage Debate
PBMs: Merck-Medco in the Hot Seat
AIDS Treatments: Discounts Here to Stay
image_tn-688-1409031563827.jpg
Chaotic Content: Streamlined Solutions
Clinical Trial: FDA Stays Silent on Trovan Charges
National Crisis Supercedes Coverage Debate
image4-686-1409031567502.gif
A Five-Year Forecast: Clear Seas Ahead?
Weak Bones, Strong Market
Weak Bones, Strong Market
Approvals: Novartis’ Silver Lining
Pfizer and others Pitch In
Oncology: EMEA Approval Lags
image_tn-687-1409031566021.jpg
BioTech's New Business Model
Illegal Sales in India
image_tn-690-1409031561989.jpg
Also Known As...The Value of Generic Names
Health Plan Premiums: Pharma Takes the Blame
Recent Videos
Marcel Botha, 10XBeta
Jennifer Kyle, Condor
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Related Content
FDA Approves AstraZeneca’s Imfinzi for Muscle-Invasive Bladder Cancer

FDA Approves AstraZeneca’s Imfinzi for Muscle-Invasive Bladder Cancer

Don Tracy, Associate Editor
March 31st 2025
Article

Approval of Imfinzi marks the first and only perioperative immunotherapy indicated for muscle-invasive bladder cancer.

Peter Ax, UpScriptHealth

Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals

Miranda Schmalfuhs
March 24th 2025
Podcast

Peter Ax, founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry and how digital health platforms could potentially help offset them.

Pharma Pulse 3/31/25: The Impact of Funding Cuts on Medical Research, Training Pharmacy Technicians as Community Health Workers & more

Pharma Pulse 3/31/25: The Impact of Funding Cuts on Medical Research, Training Pharmacy Technicians as Community Health Workers & more

Miranda Schmalfuhs
March 31st 2025
Article

The latest news for pharma industry insiders.

Jennifer Butler

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
March 11th 2025
Podcast

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.

© Dr_Microbe - © Dr_Microbe - stock.adobe.com

FDA Approves Expanded Label of Novartis’ Prostate Cancer Treatment, Pluvicto

Andy Studna
March 28th 2025
Article

Based on additional results from the Phase III PSMAfore clinical trial, the therapy is now approved for use prior to chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer.

Novo Nordisk Reaches Licensing Deal with Lexicon Pharmaceuticals for Novel Obesity Candidate

Novo Nordisk Reaches Licensing Deal with Lexicon Pharmaceuticals for Novel Obesity Candidate

Don Tracy, Associate Editor
March 28th 2025
Article

Under terms of the deal, Novo Nordisk will obtain global rights to develop, manufacture, and commercialize LX9851 for obesity and metabolic disorders.